A molecular signature determines the prognostic and therapeutic subtype of non-muscle-invasive bladder cancer responsive to intravesical Bacillus Calmette-Guérin therapy

Saved in:
Bibliographic Details
Published inEuropean urology Vol. 79; p. S614
Main Authors Yun, S.J., Kang, H.W., Kim, W.T., Kim, Y-T., Lee, S-C., Kim, W-J.
Format Journal Article
LanguageEnglish
Published 01.06.2021
Online AccessGet full text

Cover

More Information
ISSN:0302-2838
DOI:10.1016/S0302-2838(21)00826-5